title: Inducible drug modification: a new form of resistance.
authors.affiliation: a Institute for Research in Immunology and Cancer & Department of Pathology and Cell Biology; Université de Montréal ; Montréal , QC Canada.
authors.forename: Biljana
authors.initials: B
authors.lastname: Culjkovic-Kraljacic
authors.forename: Hiba Ahmad
authors.initials: HA
authors.lastname: Zahreddine
authors.forename: Katherine Lb
authors.initials: KL
authors.lastname: Borden
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry* / Q000378:metabolism* / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D005910:Glioma / Q000188:drug therapy / Q000235:genetics; D014453:Glucuronosyltransferase / Q000378:metabolism*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics; D011499:Protein Processing, Post-Translational; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D000071676:Zinc Finger Protein GLI1; D000099148:UGT1A1 Enzyme
chemical_list: D000970:Antineoplastic Agents; D014453:Glucuronosyltransferase; D014157:Transcription Factors; D000071676:Zinc Finger Protein GLI1; D000099148:UGT1A1 Enzyme; C400551:GLI1 protein, human